ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Lilly Announces Top-Line Phase 3 Results for Baricitinib Trial americanpharmaceuticalreview
February 19, 2019Eli Lilly and Company and Incyte announced baricitinib met the primary endpoint in BREEZE-AD1 and BREEZE-AD2, two Phase 3 studies evaluating the efficacy and safety of baricitinib monotherapy for the treatment of adult patients with ....
Pharma Sources Insight January 2025
